(Q37868794)

24 August 2017

1 reference

title

Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? (English)

1 reference

24 August 2017

1 reference

G Senti

1

1 reference

24 August 2017

S von Moos

series ordinal

2

1 reference

24 August 2017

Thomas M Kündig

series ordinal

3

1 reference

24 August 2017

publication date

24 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

66

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

798-809

1 reference

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Treatment strategies for allergy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Therapeutic manipulation of immune tolerance in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Immunological mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Sublingual immunotherapy: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Towards an understanding of the adjuvant action of aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Genetic allergen modification in the development of novel approaches to specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Advances in transcutaneous vaccine delivery: do all ways lead to Rome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

The 500 Dalton rule for the skin penetration of chemical compounds and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Immune surveillance in the skin: mechanisms and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Dendritic-cell control of pathogen-driven T-cell polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Harnessing human dendritic cell subsets for medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Langerhans cells as targets for immunotherapy against skin cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Friendly and dangerous signals: is the tissue in control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Epithelial decision makers: in search of the 'epimmunome'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Immunization without needles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Antigen-induced suppressor T cells from the skin point of view: suppressor T cells induced through epicutaneous immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Dissolving polymer microneedle patches for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Standardized tape stripping: a practical and reproducible protocol to uniformly reduce the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

A pilot study of the usefulness and safety of a ready-to-use atopy patch test (Diallertest) versus a comparator (Finn Chamber) during cow's milk allergy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Skin localization of cow's milk proteins delivered by a new ready-to-use atopy patch test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

An update on immunotherapy for food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

The increase in the prevalence of asthma and allergy: food for thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

Skin immunization made possible by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2011.02560.X

10.1111/J.1398-9995.2011.02560.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference